⌘K

Login Start Free

Home/Filings/4/0001144204-19-031917

4//SEC Filing

Ren Ken Keyong 4

Accession 0001144204-19-031917

CIK 0000895051other

View on SEC.gov Company Profile

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 5:01 PM ET

Size

5.4 KB

Accession

0001144204-19-031917

Insider Transaction Report

Form 4

Period: 2019-06-20

CASI Pharmaceuticals, Inc.CASI

Chief Executive Officer

Transactions

Award
Stock Option (Right to Buy)
2019-06-20+51,538→ 51,538 total
Exercise: $3.13Exp: 2029-06-20→ Common Stock (51,538 underlying)

Footnotes (1)

[F1]Stock option award will vest ratably quarterly to the end of the year.

Documents

1 file

4
tv524055_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeother

Related Parties

1

filerCIK 0001545181

Filing Metadata

Form type: 4
Filed: Jun 20, 8:00 PM ET
Accepted: Jun 21, 5:01 PM ET
Size: 5.4 KB

View on SEC.gov